Surgery Partners, Inc.
SGRY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $822 | $826 | $776 | $864 |
| % Growth | -0.6% | 6.5% | -10.2% | – |
| Cost of Goods Sold | $626 | $631 | $614 | $631 |
| Gross Profit | $195 | $196 | $162 | $234 |
| % Margin | 23.8% | 23.7% | 20.9% | 27% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $324 | $36 | $36 | $36 |
| SG&A Expenses | $324 | $36 | $36 | $36 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$234 | $48 | $64 | $71 |
| Operating Expenses | $90 | $84 | $100 | $107 |
| Operating Income | $106 | $112 | $62 | $127 |
| % Margin | 12.9% | 13.5% | 8% | 14.7% |
| Other Income/Exp. Net | -$75 | -$68 | -$62 | -$53 |
| Pre-Tax Income | $31 | $44 | -$0 | $74 |
| Tax Expense | $6 | -$1 | $0 | $121 |
| Net Income | -$23 | -$3 | -$38 | -$109 |
| % Margin | -2.8% | -0.3% | -4.9% | -12.6% |
| EPS | -0.18 | -0.02 | -0.3 | -0.86 |
| % Growth | -813.7% | 93.4% | 65.1% | – |
| EPS Diluted | -0.18 | -0.02 | -0.3 | -0.86 |
| Weighted Avg Shares Out | 127 | 127 | 127 | 126 |
| Weighted Avg Shares Out Dil | 127 | 127 | 127 | 126 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $335 | $68 | $62 | $53 |
| Depreciation & Amortization | $40 | $40 | $36 | $34 |
| EBITDA | $405 | $152 | $98 | $161 |
| % Margin | 49.3% | 18.4% | 12.7% | 18.6% |